{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:20Z","timestamp":1792110260605,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17591832"],"award-info":[{"award-number":["17591832"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20592041"],"award-info":[{"award-number":["20592041"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ophtha.2008.12.023","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T04:16:18Z","timestamp":1239855378000},"page":"1599-1603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity"],"prefix":"10.1016","volume":"116","author":[{"given":"Tatsuhiko","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujikado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2008.12.023_bib1","first-page":"262","article-title":"Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II","volume":"40","author":"Terry","year":"1942","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2008.12.023_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00129785-200303040-00004","article-title":"Retinopathy of prematurity: molecular pathology and therapeutic strategies","volume":"3","author":"Mechoulam","year":"2003","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.ophtha.2008.12.023_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.12.023_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2008.12.023_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.023_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ophtha.2008.12.023_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ophtha.2008.12.023_bib8","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"3","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2008.12.023_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2008.12.023_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.023_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMe058142","article-title":"Angiogenic pathways in diabetic retinopathy","volume":"353","author":"Aiello","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.023_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity Revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.023_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0886-3350(13)80659-1","article-title":"Posterior capsulorrhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery","volume":"20","author":"Gimbel","year":"1994","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2008.12.023_bib14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMcibr022629","article-title":"Erythropoietin\u2014an endogenous retinal survival factor","volume":"347","author":"Becerra","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.023_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/IJG.0b013e318156a556","article-title":"Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma","volume":"16","author":"Tsai","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2008.12.023_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaapos.2008.02.001","article-title":"A double-edged sword: erythropoietin eyed in retinopathy of prematurity","volume":"12","author":"Chen","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2008.12.023_bib17","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ophtha.2008.12.023_bib18","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1046\/j.1460-9568.2003.02987.x","article-title":"Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability","volume":"18","author":"Martinez-Estrada","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ophtha.2008.12.023_bib19","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1542\/peds.2005-3186","article-title":"Erythropoietin concentrations and neurodevelopmental outcome in preterm infants [online report]","volume":"118","author":"Bierer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2008.12.023_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00228-005-0896-7","article-title":"The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin","volume":"61","author":"Xenocostas","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ophtha.2008.12.023_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1203\/PDR.0b013e318165b8d1","article-title":"Elevated erythropoietin mRNA and protein concentrations in the developing human eye","volume":"63","author":"Patel","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ophtha.2008.12.023_bib22","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/dc06-0556","article-title":"Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patient with diabetic macular edema","volume":"29","author":"Hernandez","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008012773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008012773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:20Z","timestamp":1758981440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642008012773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0161642008012773"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.023","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}